Observational Study to Evaluate Fluid Resolution and Effectiveness of Brolucizumab for nAMD in Portugal
Clinical trial NCT04764656 · TERMINATED
Trial details
- NCT number
- NCT04764656
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2021-05-10
- Primary completion
- 2024-02-16
- Enrollment
- 81
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.